133 related articles for article (PubMed ID: 7926293)
1. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes.
Yu L; Gianani R; Eisenbarth GS
Diabetes; 1994 Oct; 43(10):1229-33. PubMed ID: 7926293
[TBL] [Abstract][Full Text] [Related]
2. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.
Verge CF; Gianani R; Kawasaki E; Yu L; Pietropaolo M; Jackson RA; Chase HP; Eisenbarth GS
Diabetes; 1996 Jul; 45(7):926-33. PubMed ID: 8666144
[TBL] [Abstract][Full Text] [Related]
3. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
4. Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.
Yu L; Cuthbertson DD; Maclaren N; Jackson R; Palmer JP; Orban T; Eisenbarth GS; Krischer JP;
Diabetes; 2001 Aug; 50(8):1735-40. PubMed ID: 11473032
[TBL] [Abstract][Full Text] [Related]
5. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
[TBL] [Abstract][Full Text] [Related]
8. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
[TBL] [Abstract][Full Text] [Related]
9. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.
Bingley PJ; Christie MR; Bonifacio E; Bonfanti R; Shattock M; Fonte MT; Bottazzo GF; Gale EA
Diabetes; 1994 Nov; 43(11):1304-10. PubMed ID: 7926304
[TBL] [Abstract][Full Text] [Related]
10. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. The Childhood Diabetes in Finland Study Group.
Knip M; Karjalainen J; Akerblom HK
Diabetes Care; 1998 Oct; 21(10):1670-3. PubMed ID: 9773728
[TBL] [Abstract][Full Text] [Related]
11. Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.
Bingley PJ; Williams AJ; Gale EA
Diabetes Care; 1999 Nov; 22(11):1796-801. PubMed ID: 10546010
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes: association with IA-2 and islet cell autoantibodies.
Winnock F; Christie MR; Batstra MR; Aanstoot HJ; Weets I; Decochez K; Jopart P; Nicolaij D; Gorus FK;
Diabetes Care; 2001 Jul; 24(7):1181-6. PubMed ID: 11423499
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
Myers MA; Rabin DU; Rowley MJ
Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
[TBL] [Abstract][Full Text] [Related]
14. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives.
Dittler J; Seidel D; Schenker M; Ziegler AG
Diabetes; 1998 Apr; 47(4):592-7. PubMed ID: 9568692
[TBL] [Abstract][Full Text] [Related]
15. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
Verge CF; Stenger D; Bonifacio E; Colman PG; Pilcher C; Bingley PJ; Eisenbarth GS
Diabetes; 1998 Dec; 47(12):1857-66. PubMed ID: 9836516
[TBL] [Abstract][Full Text] [Related]
16. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.
Bingley PJ; Bonifacio E; Williams AJ; Genovese S; Bottazzo GF; Gale EA
Diabetes; 1997 Nov; 46(11):1701-10. PubMed ID: 9356015
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
[TBL] [Abstract][Full Text] [Related]
18. Combined analysis of islet cell antibodies that cross-react with mouse pancreas, antibodies to the M(r) 64,000 islet protein, and antibodies to glutamate decarboxylase in type I diabetic patients.
Chaillous L; Delamaire M; Martignat L; Maugendre D; Marre M; Mathieu E; Limal JM; Charbonnel B; Allannic H; Saï P
Diabetes Care; 1994 Oct; 17(10):1115-23. PubMed ID: 7821130
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
Bergerot I; Souchier C; Thivolet C
C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
Ongagna JC; Levy-Marchal C
Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]